VERA: Vera Therapeutics, Inc. Stock

by  •  • Comments Off on VERA: Vera Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,772.20
Enterprise Value ($M) 1,182.04
Book Value ($M) 577.15
Book Value / Share 9.05
Price / Book 3.07
NCAV ($M) 572.69
NCAV / Share 8.98
Price / NCAV 3.09

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.87
Return on Equity (ROE) -1.50

Liquidity (mrq)
Quick Ratio 25.67
Current Ratio 25.67

Balance Sheet (mrq) ($M)
Current Assets 651.22
Assets 655.68
Liabilities 78.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -167.17
Net Income -152.15

Cash Flow Statement (mra) ($M)
Cash From Operations -134.68
Cash from Investing -425.03
Cash from Financing 606.67

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Avoro Capital Advisors LLC 8.90 30.17
11-14 13G/A Kynam Capital Management, LP 2.49 -56.81
11-14 13G Price T Rowe Associates Inc /md/ 7.20
11-14 13G/A Commodore Capital Lp 7.30 -28.44
11-12 13G/A Fmr Llc 5.08 0.39
11-04 13D/A Longitude Capital Partners IV, LLC 8.40 0.39
03-26 13D/A Sofinnova Venture Partners X, L.P. 5.40 -22.87
2024-02-14 13G/A Ares Trading S.A. 3.60 0.00
2024-02-14 13G/A Citadel Advisors Llc 0.10
2024-02-12 13G Woodline Partners LP 2.20

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 108,432 430,078 25.21
2025-03-10 168,738 549,189 30.72
2025-03-07 149,974 492,855 30.43
2025-03-06 170,650 766,078 22.28

(click for more detail)

Similar Companies
TVTX – Travere Therapeutics, Inc. URGN – UroGen Pharma Ltd.
VCEL – Vericel Corporation VNDA – Vanda Pharmaceuticals Inc.
VRCA – Verrica Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io